Grupo de Cáncer Endocrino Hereditario

Inicio | Investigación e innovación | Programas Científicos | Programa de Genética del Cáncer Humano | Grupo de Cáncer Endocrino Hereditario


  • Alberto Cascón
  • Cristina Rodríguez

Becarios Post-doctorales

  • Luis Javier Leandro
  • Ángel Mario Martínez
  • Cristina Montero

Becarios Pre-Doctorales

  • Javier Lanillos
  • Sara Mellid
  • María Monteagudo
  • María Santos
  • Carlos Valdivia

Técnicos de Laboratorio

  • Bruna Calsina
  • Eduardo Gil
  • Rocío Letón

Científico Visitante

  • Alberto Díaz

Our Group is mainly interested in identifying genetic risk factors involved in endocrine tumour susceptibility. Through a comprehensive analysis of tumour genomic features, we have been able to propose diagnostic and prognostic markers, to identify altered pathways that could be therapeutically targeted, and to identify new major susceptibility genes.

We are also interested in defining markers associated with differences in anticancer drug response and toxicity. We are applying targeted and whole-exome next-generation sequencing to a large series of clinically well-characterised patients. The aim is to identify new therapeutic approaches to personalise cancer treatment. These efforts will collectively improve the diagnosis, prognosis, and treatment of patients.